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1. Introduction  
In recent years, the identification of several new dystonia genes has provided important 
insights into the nature of this clinically and genetically heterogeneous disorder. Currently, 
about twenty different forms of monogenic dystonia are distinguished genetically and have 
been designated DYT 1–13; DYT 14, which has been redefined as DYT 5; and DYT 15–21 
(Ozelius et al., 2011; Wider et al., 2008). Among these DYTs, ten genes have been identified 
using linkage analysis in families:  DYT 1, 3, 5/14, 6, 8, 11, 12, 16, and 18 (See Table 1 and 
Figure 1) (Ozelius et al., 2011). 
A DYT is designated based on phenotype or chromosomal location. Therefore, it represents 
a clinically heterogeneous group of disorders that include primary dystonia, where dystonia 
is the only phenotype (DYT 1, 2, 4, 6, 7, 13, 17, and 21); dystonia plus syndromes, where 
other phenotypes in addition to dystonia, such as parkinsonism or myoclonus, are seen 
(DYT 3, 5/14, 11, 12, 15, and 16); and paroxysmal forms of dystonia/dyskinesia (DYT 8, 9, 
10, 18, 19, and 20) (Table 1) (Ozelius et al., 2011).  
2. Primary dystonia  
The clinical phenotype of primary dystonia is broad, ranging from early-onset generalized 
to late onset focal. Early-onset dystonia is rare, often starts in a limb, tends to generalize, and 
frequently has a monogenic origin. Late-onset dystonia is relatively common, rarely 
involves the lower extremities, has a tendency to remain focal, and appears to be sporadic in 
most cases (Schmidt & Klein, 2010). Six of the primary dystonia are associated with an early-
onset generalized phenotype (DYT 1, 2, 4, 6, 13, and 17), whereas two of them are 
characterized by a late-onset focal phenotype (DYT 7 and 21) (Ozelius et al., 2011). Genes 
have been identified for DYT 1 and 6 (See Table 1).  
2.1 Early-onset primary dystonia 
2.1.1 DYT1 
DYT1 dystonia is the most common and severe form of hereditary dystonia, with an 
estimated frequency of 1/9000 in the Ashkenazi Jewish and 1/160000 in the non-Jewish 
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population. The onset age of affected members ranges from 6 to 42 years, and the severity of 
the disease varies considerably. In very early-onset cases, symptoms typically begin in a 
lower limb and progress up the body over the following years. In contrast, later-onset cases 
are usually limited to upper-body parts, correlating with a somatotopic gradient in the basal 
ganglia (Bressman et al., 2000).  
 
Dystonia type  Designation Mode of inheritance      Gene locus  Protein (Gene) 
Primary dystonia 
Early-onset primary 
dystonia   
DYT1 Autosomal dominant   9q34 TorsinA (TOR1A) 
 DYT2 Autosomal recessive Unknown  Unknown  
 DYT4 Autosomal dominant Unknown  Unknown  
 DYT6 Autosomal dominant  8p21-22 Thanatos-Associated 
Protein 1 (THAP1) 
 DYT13 Autosomal dominant 1p36 Unknown  
 DYT17 Autosomal recessive  20p11-q13 Unknown  
Late-onset primary 
dystonia   
DYT7 Autosomal dominant 18p Unknown  
 DYT21 Autosomal dominant  2q14-21 Unknown  
Dystonia plus 
syndrome  
      
Dystonia plus 
parkinsonism   
DYT3 X-chromosomal recessive  Xq13 Gene transcription 
factor (TAF1)  
 DYT5/14 Autosomal dominant 14q22 GTP cyclohydrolase I 
(GCH1) 
  Autosomal recessive 11p15 Tyrosine hydroxylase 
(TH) 
 DYT12 Autosomal dominant 19q12-13 Na+/K+ATPaseǂ3 
subunit (ATP1A3) 




DYT11 Autosomal dominant  7q21 ε-sarcoglycan (SCGE) 
 DYT15 Autosomal dominant 18p11 Unknown  
Paroxysmal 
dystonia/dyskinesia
    
Non-kinesigenic 
form   
DYT8 Autosomal dominant 2q33-36 Myofibrillogenesis 
regulator 1 (MR1) 
 DYT20 Autosomal dominant 2q31 Unknown  
Kinesigenic form   DYT10 Autosomal dominant 16p11-q12 Unknown  
 DYT19 Autosomal dominant 16q13-22 Unknown  
Exercise-induced 
forms   
DYT9 Autosomal dominant 1p21-13 Unknown  
 DYT18 Autosomal dominant  1p35-31  Glucose transporter 
(SLC2A1)  
Table 1. Twenty forms of monogenic dystonia are distinguished genetically and have been 
designated DYT 1–13; DYT 14, which is redefined as DYT 5; and DYT 15–21 
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Fig. 1. Ideogram showing major chromosomal regions implicated by linkage studies of 
dystonia. Red circles indicate areas for which DYT genes have been found. Blue circles 
indicate areas for which there is suggestive evidence of linkage to different DYT loci. 
DYT1 dystonia is inherited in an autosomal dominant pattern with 30% penetrance 
(Bressman et al., 2000). Regardless of ethnic background, most cases are caused by a three 
base pair (GAG) deletion in the coding region of the TOR1A gene on chromosome 9q34, 
leading to the loss of a glutamic acid in the carboxy terminal region of the encoded protein 
TorsinA (Ozelius et al., 1997). The Asparagine to Histidine substitution at position 216 
moderates the effects of the DYT1 GAG deletion. Haplotype analysis demonstrates Asp216 
in cis is required for the disease to be penetrant (Risch et al., 2007). 
TorsinA is a member of the AAA family (ATPases Associated with diverse cellular 
Activities), which has many different functions, including cytoskeletal dynamics, protein 
processing and degradation, vesicle recycling, and intracellular trafficking (Neuwald et al., 
1999). TorsinA is predominantly located within the lumen of the endoplasmatic reticulum. 
The mutant form relocates to the nuclear envelope, where it alters connections between the 
inner and outer nuclear membranes, suggesting DYT1 dystonia may be one of a group of 
diseases associated with defects in nuclear membrane structure and function (Goodchild & 
Dauer, 2004; Naismith et al., 2004). In addition, loss of TorsinA activity would lead to a 
dysfunction of protein processing through the secretary pathway and defective degradation 
of mutant proteins in the cell (Hewett et al., 2007). Furthermore, TorsinA is expressed 
prominently in the substantia nigra, and its staining pattern is granular and present in the 
neuronal processes, suggesting that DYT1 dystonia may be associated with a dysfunction of 
dopamine transmission (Konakova et al., 2001; Shashidharan et al., 2005).  
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DYT2 dystonia is clinically similar to DYT1 dystonia, but it is inherited in an autosomal 
recessive manner (Schmidt & Klein, 2010). Nevertheless, some experts posit that DYT2 
dystonia is unlikely for recessive inheritance but is consistent with dominant inheritance 
with low penetrance (Zlotogora, 2004). Until now, no gene locus has been identified.  
2.1.3 DYT4 
DYT4 dystonia has been described in a large Australian family containing members of at 
least five generations distributed in an autosomal dominant pedigree pattern. Onset age 
ranges from 13 to 37 years. Dystonia first involves speech, then torticollis, and later develops 
dysphonia. Some patients have been identified with Wilson disease (Ahmad et al., 1993). 
Until now, no gene locus has been identified. Linkage studies exclude location of the 
responsible locus on 9q (see DYT1) (Ahmad et al., 1993). Investigation for linkage using 
markers flanking the Wilson disease locus likewise also yields negative results (Ahmad et 
al., 1993).  
2.1.4 DYT6 
DYT6 dystonia is characterized by early involvement of craniofacial muscles with secondary 
generalization often involving the arms and is characterized by laryngeal dystonia that 
causes speech difficulties. The mean age at onset is 16 years, with more than half of the 
patients developing symptoms before age 16 years. It is inherited in an autosomal dominant 
pattern with 60% penetrance (Djarmati et al., 2009).  
DYT6 dystonia is caused by mutations in the THAP1 gene, which encodes the Thanatos-
Associated Protein 1 on chromosome 8p21-22 (Schmidt & Klein, 2010). The protein belongs 
to the family of sequence-specific DNA-binding cellular factors that functions as a nuclear 
proapoptotic protein and regulates endothelial cell proliferation (Kaiser et al., 2010). THAP1 
interacts with prostate apoptosis response 4 protein (Par-4) (Roussigne et al., 2003), an 
effector of cell death linked to neurodegenerative diseases, including Parkinson’s disease 
(Duan et al., 1999). Additionally, THAP1 has been shown to bind to the TorsinA promoter 
and repress its expression. DNA binding is disrupted and expression decreased by 
pathogenic THAP1 mutations (Kaiser et al., 2010). These data link the molecular pathways 
underlying DYT1 and DYT6 dystonia and highlight transcriptional dysregulation as a cause 
of primary dystonia (Gavarini et al., 2010).  
2.1.5 DYT13 
DYT13 dystonia is reported in a large non-Jewish Italian family with autosomal dominant 
idiopathic torsion dystonia spanning three generations. Eight members have definite torsion 
dystonia characterized by average onset at 15 years of age, symptoms beginning in the 
cervical or craniocervical region or in the upper limbs, and slow progression to other body 
regions (more than 18 years). Two treated patients are unresponsive to dopaminergic 
medication (Bentivoglio et al., 1997). Linkage analysis on this family identifies a locus within 
a 22-cM interval on chromosome 1p36 (Valente et al., 2001). 
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DYT17 dystonia is reported in a large, consanguineous Lebanese family, in which three 
sisters have primary focal torsion dystonia beginning with torticollis at ages 17, 19, and 14 
years, respectively. Two years after onset, the symptoms spread, causing segmental 
dystonia for two patients and generalized dystonia for the third. At the time of examination, 
when the sisters were in their thirties, all had severe dysphonia and dysarthria (Chouery et 
al., 2008). DYT17 dystonia is inherited in an autosomal recessive manner. The responsible 
gene locus is linked to a 20.5-Mb interval on chromosome 20p11-q13 (Chouery et al., 2008).  
2.2 Late-onset primary dystonia 
2.2.1 DYT7 
DYT7 dystonia was first described in a German family. Family members are primarily 
affected with cervical dystonia beginning in mid-adulthood (mean age of onset: 43). The 
dystonic symptoms remain focal in all cases of over 9 years of disease duration (Leube et al., 
1996). The mode of inheritance is autosomal dominant with reduced penetrance. The family 
shows linkage to chromosome 18p (Leube et al., 1996). Following the above study, eighteen 
nuclear adult-onset focal dystonia families from central Europe were studied by genotyping 
with 18p microsatellites. In three families, the affected relatives do not share an 18p 
haplotype, suggesting locus heterogeneity in this disorder (Leube et al., 1997).  
2.2.2 DYT21 
DYT21 dystonia was first described in a family from northern Sweden. The phenotype in 
this family is characterized by later onset (mean: 27 years; range, 13-50 years) and mainly 
multifocal dystonia, with onset in the cranial/cervical muscles in most and the hands in 
about 25% (Norgren et al., 2011). The disease is inherited in an autosomal dominant manner 
with a penetrance that may be as high as 90%. The DYT21 locus in this family is mapped to 
chromosome 2q14-21 (Norgren et al., 2011).  
3. Dystonia plus syndrome 
Dystonia associated with but not secondary to other movement disorders, such as 
parkinsonism or myoclonus, are classified as dystonia plus syndrome (Schmidt & Klein, 
2010). Within the dystonia plus classification there are four forms that include parkinsonism 
as part of their phenotype (DYT 3, 5/14, 12, and 16), and two that have myoclonus in 
addition to dystonia (DYT 11 and 15). Genes have been identified for all these forms except 
DYT 15 (Ozelius et al., 2011). 
3.1 Dystonia plus parkinsonism 
3.1.1 DYT3 
DYT3 dystonia was first identified in an island of the Philippines (Lee et al., 1976). First 
manifestations are noted in the head and neck in 39%, in the lower limbs in 33%, in the 
upper limbs in 24%, and in the trunk in 9%. At least one “parkinsonian symptom” 
(bradykinesia, rigidity, loss of postural reflexes, and resting tremor) is found in 36% of the 
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cases. The mean age of onset is 34.8 years, which is similar to that in the adult-onset 
autosomal dominant form. Nevertheless, DYT3 dystonia tends to generalize in most patients 
within 7 years of onset (Kupke et al., 1990b; Lee et al., 2011).  
DYT3 dystonia is inherited in an X-linked recessive pattern (Kupke et al., 1990a). It is caused 
by an SVA (short interspersed nuclear element, variable number of tandem repeats, and Alu 
composite) retrotransposon insertion in intron 32 of the TAF1 gene (TATA box binding 
protein associated factor) on Xq13, which encodes the largest component of the TFIID 
complex (Makino et al., 2007; Pasco et al., 2011). The insertion is 2,627 bp in length. SVA 
retrotransposon insertions are thought to be active in the human genome and are thought to 
alter the expression level of adjacent genes that cause diseases. The insertion has a high GC 
content (approximately 70%) and a large number of CpG sites (more than 150) in its 
nucleotide sequence, so it is frequently hypermethylated in its insertion site (Hancks & 
Kazazian, 2010). In DYT3 dystonia, the decreased expression of the neuron-specific TA14-
391 isoform, and probably other TAF1 isoforms, results in transcriptional dysregulation of 
many neuronal genes, including that which encodes the dopamine receptor (Makino et al., 
2007; Pasco et al., 2011).  
3.1.2 DYT5/14 
The symptom presentation of DYT5 dystonia ranges from spasticity in early childhood to 
dystonia in mid-childhood, and finally becomes parkinsonism in later life. It is characterized 
by a dramatic response to L-dopa therapy and by diurnal fluctuation in the severity of 
symptoms (Ozelius et al., 2011).  
DYT5 dystonia is inherited in either an autosomal dominant or recessive manner. The 
autosomal dominant form is mostly caused by mutations in the gene encoding GTP 
cyclohydrolase I (GCH1) on chromosome 14q22 (Ichinose et al., 1994). GCH1 is rate-limiting 
in the conversion of GTP to tetrahydrobiopterin (BH4), the cofactor for tyrosine hydroxylase 
(TH), which is the rate-limiting enzyme for dopamine synthesis (Gesierich et al., 2003). An 
autosomal recessive form of DYT5 dystonia that is associated with infantile parkinsonism is 
caused by mutations in the TH gene on chromosome 11p15 (Gorke & Bartholome, 1990). 
Other forms of DYT5 dystonia result from a deficiency of other enzymes in the biosynthetic 
pathway for biopterins, such as sepiapterin reductase (Asmus & Gasser, 2010). All of these 
defects diminish the activity of TH, which explains the molecular basis for the efficacy of L-
dopa treatment, as this drug bypasses the enzymatic defect (Breakefield et al., 2008). The 
diurnal variation of symptoms, which typically are worse during the course of the day and 
improve overnight with sleep, is thought to derive from use-dependent depletion of BH4 in 
dopamine-producing neurons (Breakefield et al., 2008). 
A dopa-responsive dystonia in the family reported by Grotzsch et al. was originally thought 
to be at a locus on chromosome 14, separate from the DYT5 locus, and was designated 
DYT14 (Grotzsch et al., 2002). Wider et al. restudied the same family and determined that 
the disorder is indeed DYT5 caused by mutation in the GCH1 gene (Wider et al., 2008). 
3.1.3 DYT12 
DYT12 dystonia is characterized by abrupt onset of dystonia with parkinsonism over a few 
minutes to 30 days, a clear rostrocaudal (face, arm, leg) gradient of involvement, and 
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prominent bulbar findings, and it is triggered by stress. Onset age is usually in late 
adolescence or early adulthood (range 15 to 45 years). Treatment with dopaminergic 
medications is usually not effective (Brashear et al., 2007). 
DYT12 dystonia is inherited in an autosomal dominant pattern with reduced penetrance. 
It is caused by heterozygous mutations in the ATP1A3 gene encoding the ǂ3 subunit of 
the Na+/K+ATPase on chromosome 19q12-13 (de Carvalho Aguiar et al., 2004). 
Na+/K+ATPase maintains an electrochemical gradient across the plasma membrane. It 
consists of ǂ, ǃ, and Ǆ subunits, with the human ǂ3 subunit only expressed in the brain 
and heart, indicating a specialized role in excitable tissues (Hilgenberg et al., 2006). DYT12 
dystonia could result from reduced function of this ion transporter and could appear to 
exacerbate the physiologic response to stress, as in stress-induced channelopathies 
(Cannon, 2006). 
3.1.4 DYT16 
DYT16 dystonia is characterized by early-onset (2-18 years) gait abnormalities and leg pain, 
followed by dysphagia, spasmodic dysphonia generalized dystonia, torticollis, upper limb 
dystonia, and opisthotonic posturing. Orofacial dystonia and facial grimacing are prominent 
features. Possible parkinsonian signs are reported in a minority of patients, are limited to 
bradykinesia in the presence of severe generalized dystonia, and are not responsive to 
dopaminergic medication (Camargos et al., 2008). 
DYT16 dystonia is inherited in an autosomal recessive pattern. It is caused by mutations in 
the PRKRA gene on chromosome 2q31, which encodes the protein kinase, interferon-
inducible double-stranded RNA-dependent activator (Camargos et al., 2008; Seibler et al., 
2008). The function of the protein remains largely unknown. 
3.2 Dystonia plus myoclonus 
3.2.1 DYT11 
DYT11 dystonia is characterized by myoclonic jerks affecting mostly proximal muscles, 
occurring at rest and increasing with activity or changes in posture. Onset age is in 
childhood or adolescence. Symptoms often respond to alcohol, and patients may have 
psychiatric abnormalities (Saunders-Pullman et al., 2002).  
DYT11 dystonia is inherited in an autosomal dominant pattern. It is caused by loss-of-
function mutations in the SGCE gene encoding ε-sarcoglycan on chromosome 7q21. 
Maternal imprinting of SGCE results in reduced penetrance of the disorder when the 
mutation is inherited from the mother (Zimprich et al., 2001). ε-sarcoglycan is highly 
expressed during brain development and is highly expressed in dopaminergic neurons, as 
well as in other neuronal subtypes (Chan et al., 2005). The mutant proteins are unable to 
reach the cell surface and are retained intracellular and degraded (Esapa et al., 2007). The 
exact pathophysiology is thought to be similar to the sarcoglycans that are mutated in limb 
girdle muscular dystrophies (Chen et al., 2006). More studies are needed to determine 
whether ε-sarcoglycan participates in the formation of dystrophin-glycoprotein complexes 
in the brain like it does in muscles. 
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DYT15 dystonia is reported in a large Canadian family, in which twelve members over four 
generations have alcohol-responsive myoclonic dystonia characterized by jerky movements 
of the upper limbs, hands, and axial muscles. Four members also have dystonia of the upper 
limbs, and one has dystonia of the leg (Grimes et al., 2001). Mutation in the SGCE gene is 
excluded (DYT11), and linkage of the disorder to a 17-cM region on chromosome 18p11 is 
seen. Two unaffected obligate carriers and all affected members carried the same haplotype. 
Five other unaffected members also carried at least part of the haplotype, suggesting 
reduced penetrance of the disorder in this family (Grimes et al., 2001).  
4. Paroxysmal dystonia/dyskinesia 
This is a heterogeneous group of disorders characterized by sudden transient attacks of 
involuntary movements. They are subdivided into non-kinesigenic (DYT 8 and 20), 
kinesigenic (DYT 10 and 19), and exercise-induced forms (DYT 9 and 18). The genes for DYT 
8 and 18 have been identified (Ozelius et al., 2011). 
4.1 Non-kinesigenic form 
4.1.1 DYT8 
DYT8 dystonia is characterized by attacks of uncontrollable dystonic choreoathetosis and 
onset in infancy or childhood. The attacks last only a few minutes, occur a few times a day, 
and are not accompanied by unconsciousness. Alcohol, coffee, hunger, fatigue, and tobacco 
are precipitating factors. Between attacks, affected individuals are phenotypically normal 
(Ozelius et al., 2011).  
DYT8 dystonia is inherited in an autosomal dominant pattern with incomplete penetrance. 
It is caused by mutations in the gene for the myofibrillogenesis regulator-1 (MR1) on 
chromosome 2q33-36, which lead to valine-to-alanine substitutions at positions 7 and 9 and 
also are predicted to disrupt ǂ-helix structures of MR1 proteins (Rainier et al., 2004). MR1 
long isoform (MR1L) is likely to have similar enzymatic activity to hydroxyl-acyl 
glutathione hydrolase (HAGH), which functions in a pathway to detoxify methylglyoxal, a 
compound present in coffee and alcoholic beverages and produced as a byproduct of 
oxidative stress (Lee et al., 2004). Thus, in this form of dystonia, toxins and stress could 
combine with abnormal MR-1 activity to exacerbate neuronal toxicity. Recently, a mutation 
in the N-terminal mitochondrial targeting sequence (MTS) of the MR1 gene has been 
reported in a three-generation family (Ghezzi et al., 2009). Their results differ from the above 
findings with regard to localization of the MR1L and suggest a novel disease mechanism 
based on a deleterious action of the MTS. 
4.1.2 DYT20 
DYT20 dystonia was reported in a Canadian family of European descent, in which 10 
members spanning 4 generations have PNKD. This disorder is characterized by episodic 
dystonia primarily affecting the hands and feet symmetrically. Age at onset ranged from 
childhood to age 50 years. Episodes last 2 to 5 minutes (up to 10 minutes in 1 patient) and 
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occur daily or several times per month. Alcohol, caffeine, and excitement are not obvious 
triggers (Spacey et al., 2006).  
DYT20 dystonia is inherited in an autosomal dominant manner. The gene locus is linked to 
chromosome 2q31, which is distinct from the DYT8 locus on chromosome 2q33-36 (Spacey et 
al., 2006).  
4.2 Kinesigenic form 
4.2.1 DYT10 
DYT10 dystonia is characterized by recurrent and brief attacks of involuntary movement 
precipitated by sudden unexpected movements. Onset age is in childhood or adolescence. It 
differs from the DYT8 dystonia by later onset in many cases; by briefer duration of attacks 
(seconds to minutes), which usually occur daily; and by good response to anticonvulsants. 
About 40% of patients have afebrile, general convulsions in infancy (Bennett et al., 2000). 
Both autosomal dominant and autosomal recessive inheritance of this disorder is proposed. 
The cases interpreted as autosomal recessive may have been instances of reduced 
penetrance in an affected parent or new mutation. The gene locus maps to chromosome 
16p11-q12 (Tomita et al., 1999). DYT10 dystonia shares some clinical features with benign 
familial infantile convulsions (BFIC2) and with infantile convulsions and paroxysmal 
choreoathetosis (ICCA). The three disorders overlap across a pericentromeric region of 
chromosome 16, suggesting that they may be allelic disorders (Caraballo et al., 2001). 
4.2.2 DYT19 
DYT 19 dystonia is reported in a large Indian clan in which thirteen individuals have 
received a definite diagnosis. The onset age ranges from 7 to 13 years. It is characterized by 
brief attacks of up to 2 minutes consisting of dystonic or choreic movements precipitated by 
sudden movements, with a frequency of 1 to 20 episodes per day. None of the affected 
patients have a history of benign infantile convulsions. Some of them, however, have 
sporadic episodes of generalized tonic-clonic seizures in their teenage years that 
spontaneously resolve (Valente et al., 2000).  
DYT19 dystonia is inherited in an autosomal dominant manner with incomplete penetrance 
(75%). The gene locus is linked to chromosome 16q13-22, which is distinct from the DYT10 
locus (16p11-q12) (Valente et al., 2000). 
4.3 Exercise-induced form 
4.3.1 DYT9 
DYT9 dystonia is characterized by paroxysmal choreoathetosis, ataxia, and spasticity. Onset 
age ranges from 2 to 15 years, with most patients presenting clear symptoms before 
attending school. The episodes last approximately 20 minutes and occur at frequencies 
ranging from twice a day to twice a year. The involuntary movements and dystonia are 
similar to those in DYT8 dystonia. In both disorders, episodes can be induced by alcohol, 
fatigue, and emotional stress; nevertheless, in DYT9 dystonia, physical exercise can 
precipitate the episodes (Auburger et al., 1996). 
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Inheritance is clearly autosomal dominant. By linkage analysis, the gene for this disorder 
probably lies in a 2-cM region on chromosome 1p21-13, where a cluster of potassium 
channel genes is located. Until now, the precise gene locus has not been identified 
(Auburger et al., 1996).  
4.3.2 DYT18 
DYT18 dystonia is characterized primarily by onset in childhood of paroxysmal exercise-
induced dyskinesia. The dyskinesia involves transient abnormal involuntary movements, 
such as dystonia and choreoathetosis, induced by exercise or exertion, and affecting the 
exercised limbs. Some patients may also have epilepsy, most commonly childhood absence 
epilepsy, with an average onset of about 2 to 3 years. Mild mental retardation may also 
occur (Margari et al., 2000). 
DYT18 dystonia is inherited in an autosomal dominant manner. It is caused by 
heterozygous mutations in the SLC2A1 gene, which encodes the GLUT1 transporter, on 
chromosome 1p35-31 (Schneider et al., 2009; Weber et al., 2008). A defect in the GLUT1 
glucose transporter causing decreased glucose concentration in the central nervous system is 
part of a spectrum of neurologic phenotypes resulting from GLUT1 deficiency. A ketogenic 
diet often results in marked clinical improvement of the motor and seizure symptoms 
(Kamm et al., 2007; Pascual et al., 2004) 
5. Conclusion 
Currently, the dystonias represent a clinically and genetically heterogeneous set of 
movement disorders. Although the identified dystonia genes are diverse and the underlying 
mechanisms of how they cause dystonia remain wanting, their identification has led basic 
research to understand the pathophysiology of dystonia. For example, DYT6 THAP1 has 
been shown to bind to the DYT 1 TorsinA promoter and repress its expression (Kaiser et al., 
2010), suggesting that common pathways may be involved in dystonia, and novel 
treatments targeting these common pathways may be effective for the treatment of different 
forms of dystonia. Next, better understanding of the underlying mechanisms of these 
dystonia genes and their interactions would allow researchers to compare and reclassify the 
dystonia subtypes that would help direct therapies and define endophenotypes. Finally, 
new genetic technologies, including SNP based genome-wide association study, microarray 
comparative genomic hybridization study, next-generation exomic and whole-genome 
sequencing, should accelerate gene discovery for dystonias that should further elucidate the 
underlying pathways. 
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